Vanta Bioscience Ltd share price logo

Vanta Bioscience Ltd Share Price

22.03

-1.15

(-4.96%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Vanta Bioscience Ltd Stock Performance

as on September 3, 2025 at 4:01 pm IST

  • ₹22.03
    ₹22.03
  • 52 Week's Low

    52 Week's High

    ₹19.08
    ₹56
    downward going graph

    13.39%

    Downside

    154.20%

    Upside

    downward going graph

Vanta Bioscience Ltd share price movements today

Previous Close
₹23.18
Open
₹22.03
Volume
750.00
Upper Circuit
₹24.33
Lower Circuit
₹22.03
Day's Low - High
₹22.03 - ₹22.03
52 Week Low - High
₹19.08 - ₹56

Vanta Bioscience Ltd Historical Returns

1 Month Return
-9.24 %
3 Month Return
-10.12 %
1 Year Return
-50.36 %
3 Year Return
-76.15 %
5 Year Return
-86.12 %

Vanta Bioscience Ltd Fundamentals

as on September 3, 2025 at 4:01 pm IST

Market Cap

₹14.63 Cr

Return on Equity (ROE)

0.05

PE Ratio (TTM)

0

Return on capital employed (ROCE)

5.24

Beta (LTM)

0.58

P/B Ratio

2.04

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

0

EPS (TTM)

-13.63

Sector

FMCG

Book Value

24.08

Technical Analysis

Vanta Bioscience Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vanta Bioscience Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA14.63-17.22%0.90-99
NA208.10-8.94%0.784435
NA53.34-9.78%0.00-446
NA131.4669.24%0.00241
NA165.1627.79%0.00-19

Vanta Bioscience Ltd Stock's Interest Amongst Investors

Search interest for Vanta Bioscience Ltd Stock has decreased by -37% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-37% versus previous 30 day period

Vanta Bioscience Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Sales
2.82
0.63
Other Income
0.01
0.67
Total Income
2.83
1.29
Expenses
3.37
1.93
Operating Profit
-0.55
-1.3
Operating Profit Margin %
-19.5%
-206.35%
Profit Before Interest, Tax and Depreciation
-0.54
-0.63
Interest
2.48
0.92
Depreciation
1.31
0.05
Profit Before Tax
-4.33
-1.6
Tax Paid
0.09
-0.01
Profit After Tax
-2.56
-1.36
Total Net profit including share of profit / Loss from associate company
-2.56
-1.36
EPS
-4.06
-
Actual EPS
-4.06
-
Adjusted EPS
-4.06
-
Diluted EPS
-4.06
-

Vanta Bioscience Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
3.99
12.48
14.14
10.04
9.69
6.28
9.72
1.96
Other Income
0.05
0.23
0.11
0.03
0.42
0.69
0.11
0.11
Total Income
4.04
12.71
14.25
10.07
10.11
6.96
9.83
2.07
Expenses
2.96
9.21
9.77
6.09
6.22
8.67
8.41
6.22
Operating Profit
1.03
3.27
4.37
3.95
3.47
-2.39
1.31
-4.26
Operating Profit Margin %
25.81%
26.2%
30.91%
39.34%
35.81%
-38.06%
13.48%
-217.35%
Profit Before Interest, Tax and Depreciation
1.08
3.5
4.48
3.98
3.89
-1.71
1.42
-4.15
Interest
0.2
1.69
1.95
2.14
2.35
5.89
5.75
4.07
Depreciation
0.57
0.71
1.19
1.25
1.32
2.67
4.5
4.42
Profit Before Tax
0.31
1.1
1.34
0.59
0.22
-10.27
-8.83
-12.64
Tax Paid
0.29
0.4
0.34
0.14
0.14
0.18
-0.22
0.66
Profit After Tax
0.03
0.7
1
0.45
0.09
-6.48
-2.32
-4.77
Total Net profit including share of profit / Loss from associate company
0.03
0.7
1
0.45
0.09
-6.48
-2.32
-4.77
EPS
0.05
1.19
1.59
0.71
0.14
-10.27
-3.67
-7.56
Actual EPS
0.05
1.19
1.59
0.71
0.14
-10.27
-3.67
-7.56
Adjusted EPS
0.05
1.19
1.59
0.71
0.14
-10.27
-3.67
-7.56
Diluted EPS
0.05
1.19
1.59
0.71
0.14
-10.27
-3.67
-7.56

Vanta Bioscience Ltd Cash Flow

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Net Cash from Operating Activities
-1.04
2.34
6.97
5.28
-0.63
2.68
Cash Flow from Investing Activities
-5.73
-0.59
-0.96
-0.39
-28.69
-3.31
Cash Flow from Financing Activities
9.94
2.17
17.78
9.53
6.4
0.7
Net Cash Flow
3.18
-3.07
2.46
-2.43
-0.13
0.06

Vanta Bioscience Ltd Stock Shareholding Pattern

Numbers in percentages

Sep 2022
Mar 2023
Sep 2023
Mar 2024
Sep 2024
Mar 2025
Promoters
69.36%
69.36%
69.36%
69.36%
69.36%
69.36%
Public
30.64%
30.64%
30.64%
30.64%
30.64%
30.64%
Total Outstanding Shares
63,12,000
63,12,000
63,12,000
63,12,000
63,12,000
63,12,000
Total Shareholders
393
394
388
418
424
408

Vanta Bioscience Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Vanta Bioscience Ltd.

  • Vanta Bioscience Ltd Earnings Results

    Vanta Bioscience Ltd’s net profit fell -2042.86% since last year same period to ₹-1.36Cr in the Q4 2022-2023. On a quarterly growth basis, Vanta Bioscience Ltd has generated 46.88% jump in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Vanta Bioscience Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vimta Labs Ltd has given 326.3% return, outperforming this stock by 402.4%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 30.64% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Vimta Labs Ltd has given 145.3% return, outperforming this stock by 195.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 69.36% of holdings in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, Vanta Bioscience stock has moved down by -5.0%

About Vanta Bioscience Ltd

Vanta Bioscience Limited (VBS) is an Indian preclinical contract research organization established in 2016, specializing in preclinical safety assessments services for the Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics and Chemical industries. It provides risk assessment services and expert services which involve the determination of health based exposure limits such as permitted daily exposure (PDE) and allowable daily exposure (ADE), including occupational exposure limits (OEL). VBS has state-of-the-art preclinical CRO facilities set up in Gummidipundi, Chennai, and conducts a variety of in vivo and in vitro studies for its clients as they strive for regulatory approval worldwide. Their services also involve preclinical proof-of-concept (POC) studies which involve the validation of new pharmaceuticals and products intended for novel indications. With a dedicated team of promoters and experienced researchers, VBS continues to be a major player in the preclinical research space in India.

Revenue: ₹0.63Cr as on March 2023 (Q4 FY23)
Net Profit: ₹-1.36Cr as on March 2023 (Q4 FY23)
Chairperson Name: Mohan Krishna Mulakala
OrganisationVanta Bioscience Ltd
IndustryFMCG
CEOMohan Krishna Mulakala
E-voting on sharesClick here to vote

FAQs

What is Vanta Bioscience Ltd share price today?

Vanta Bioscience Ltd share price today stands at ₹22.03 as on at the close of the market. Vanta Bioscience Ltd share today touched a day high of ₹22.03 and a low of ₹22.03.

What is the 52 week high and 52 week low range for Vanta Bioscience Ltd share?

Vanta Bioscience Ltd touched a 52 week high of ₹56 and a 52 week low of ₹19.08. Vanta Bioscience Ltd share price today i.e. is closed at ₹22.03, which is -60.66% down from its 52 week high and 15.46% up from its 52 week low.

What is Vanta Bioscience Ltd's market capitalisation today?

Vanta Bioscience Ltd market capitalisation is ₹14.63 Cr as on .

How to buy Vanta Bioscience Ltd shares?

To buy Vanta Bioscience Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 540729 or Vanta Bioscience Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Vanta Bioscience Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Vanta Bioscience Ltd trading volume today?

Vanta Bioscience Ltd trading volume is 750.00 as on . This means that 750.00 shares of Vanta Bioscience Ltd were bought and sold on the stock market during today's trading session.